JamesF. Bishop
Impact in
- Biochemistry top 5%
- Blood transfusion and management
- Hematology top 5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
Papers in
-
- Acute Myeloid Leukemia Research 3
- Blood groups and transfusion 2
-
- Blood transfusion and management 3
- Co-authors
- K. Yuen (4 shared papers)Kathy M. McGrath (4 shared papers)M. Wolf (4 shared papers)Jeff Szer (4 shared papers)Ian Olver (4 shared papers)Derek Raghavan (3 shared papers)Jane Matthews (3 shared papers)Richard S. Kaplan (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Transfusion Medicine (2 papers)Lung Cancer (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of AOAC International (1 paper)
- Partner nations
- AustraliaUnited StatesBelgium
In The Last Decade
JamesF. Bishop
20 papers receiving 685 citations
Peers
Comparison fields: 5 of 60
- Biochemistry 128
- Hematology 203
- Oncology 268
- Dermatology 93
- Pulmonary and Respiratory Medicine 206
Countries citing papers authored by JamesF. Bishop
This map shows the geographic impact of JamesF. Bishop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JamesF. Bishop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JamesF. Bishop more than expected).
Fields of papers citing papers by JamesF. Bishop
This network shows the impact of papers produced by JamesF. Bishop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JamesF. Bishop. The network helps show where JamesF. Bishop may publish in the future.
Co-authors
The 25 scholars most cited alongside JamesF. Bishop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 98 | |
| 2 | 1991 | 95 | |
| 3 | 1988 | 93 | |
| 4 | 1998 | 82 | |
| 5 | 1990 | 74 | |
| 6 | 1996 | 67 | |
| 7 | 1992 | 58 | |
| 8 | 1979 | 52 | |
| 9 | 1988 | 47 | |
| 10 | 1987 | 30 | |
| 11 | 1995 | 24 | |
| 12 | A randomized trial of high dose cyclophosphamide, vincristine, and prednisone plus or minus doxorubicin (CVP versus CAVP) with long-term follow-up in advanced non-Hodgkin's lymphoma. | 1987 | 10 |
| 13 | 1989 | 8 | |
| 14 | 1994 | 8 | |
| 15 | 1991 | 5 | |
| 16 | 2000 | 5 | |
| 17 | 1983 | 3 | |
| 18 | 2010 | 2 | |
| 19 | 1982 | 2 | |
| 20 | Does it matter how remission is achieved in acute leukemia? | 1996 | 2 |
About JamesF. Bishop
JamesF. Bishop is a scholar working on Hematology, Biochemistry, Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 766 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers), Blood transfusion and management (3 papers), Acute Myeloid Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Neutropenia and Cancer Infections (3 papers), Cancer therapeutics and mechanisms (3 papers) and Blood groups and transfusion (2 papers). The work is most often cited by research in Biochemistry (128 citations), Hematology (203 citations), Oncology (268 citations), Dermatology (93 citations) and Pulmonary and Respiratory Medicine (206 citations). JamesF. Bishop has collaborated with scholars based in Australia, United States and Belgium. Frequent co-authors include K. Yuen, Kathy M. McGrath, M. Wolf, Jeff Szer, Ian Olver, Derek Raghavan, Jane Matthews, Richard S. Kaplan, Joseph Aisner and George Morstyn. Their work appears in journals such as Journal of Clinical Oncology, Transfusion Medicine, Lung Cancer, Cancer Chemotherapy and Pharmacology and Journal of AOAC International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.